EUVIMEDEUVIMED entdecken
Crossref

Correction. The Efficacy of Olanzapine/Samidorphan on Negative Symptoms

The Journal of Clinical Psychiatry · 25.03.2026 · 87 (2)

DOI: 10.4088/jcp.26lcx16443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 25.03.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the article “The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia” by Roger S. McIntyre, MD; Desiree M. Matthews, PMHNP-BC; Christina Arevalo, MS; David McDonnell, MD; and Christoph U. Correll, MD, published online March 9, 2026 (J Clin Psychiatry 2026;87[2]:25m16170), data shown in the “Predominant negative […]

Zitieren

APA

(2026). Correction. The Efficacy of Olanzapine/Samidorphan on Negative Symptoms. The Journal of Clinical Psychiatry, 87(2). https://doi.org/10.4088/jcp.26lcx16443

Vancouver

Correction. The Efficacy of Olanzapine/Samidorphan on Negative Symptoms. The Journal of Clinical Psychiatry. 2026;87(2). doi:10.4088/jcp.26lcx16443

BibTeX
@article{euvimed2026,
  title = {Correction. The Efficacy of Olanzapine/Samidorphan on Negative Symptoms},
  journal = {The Journal of Clinical Psychiatry},
  year = {2026},
  volume = {87},
  number = {2},
  doi = {10.4088/jcp.26lcx16443}
}
Kostenlos starten →